Detalles de la búsqueda
1.
Advanced Age and Increased Risk for Severe Outcomes of Dengue Infection, Taiwan, 2014-2015.
Emerg Infect Dis
; 29(8): 1701-1702, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486786
2.
Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study.
J Formos Med Assoc
; 122(11): 1165-1173, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321955
3.
Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P.
J Infect Dis
; 226(9): 1562-1567, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35451470
4.
Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
Clin Infect Dis
; 74(11): 1899-1905, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34739037
5.
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine.
Vaccine
; 41(15): 2615-2629, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36925422
6.
An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay.
Vaccine
; 41(1): 109-118, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404171
7.
Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial.
Vaccine
; 41(23): 3497-3505, 2023 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080829
8.
Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study.
Vaccines (Basel)
; 11(12)2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140202
9.
Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study.
Infect Dis Ther
; 11(4): 1493-1504, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579840
10.
Population-based assessment of factors influencing antibiotic prescribing for adults with dengue infection in Taiwan.
PLoS Negl Trop Dis
; 16(2): e0010198, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35226674
11.
Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine.
Sci Rep
; 12(1): 11369, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790783
12.
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial.
NPJ Vaccines
; 7(1): 165, 2022 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36526640
13.
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
PLoS One
; 17(11): e0272594, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36322572
14.
Safety and immunogenicity of MVC-COV1901 vaccine in older adults: Phase 2 randomized dose-comparison trial.
Int J Infect Dis
; 124: 21-26, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049700
15.
A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV.
Vaccines (Basel)
; 11(1)2022 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36679862
16.
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.
Theranostics
; 12(1): 1-17, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34987630
17.
A Population-Based Cohort Study on Chronic Comorbidity Risk Factors for Adverse Dengue Outcomes.
Am J Trop Med Hyg
; 105(6): 1544-1551, 2021 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34583328
18.
Assessing the International Transferability of a Machine Learning Model for Detecting Medication Error in the General Internal Medicine Clinic: Multicenter Preliminary Validation Study.
JMIR Med Inform
; 9(1): e23454, 2021 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502331
19.
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan.
Lancet Respir Med
; 9(12): 1396-1406, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34655522
20.
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.
Sci Rep
; 11(1): 8761, 2021 04 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33888840